Hill-Rom Hits New 52-Week High: What's Driving the Stock?HomeMailNewsFinanceSportsEntertainmentSearchMobileMore...YAHOO_FINANCESearchSign inMailSign in to view your mailFinance HomeWatchlistsMy PortfolioScreenersPremiumMarketsIndustriesPersonal FinanceVideosNewsTechU.S. Markets closedS&P 5002,978.76-137.63(-4.42%)Dow 3025,766.64-1,190.95(-4.42%)Nasdaq8,566.48-414.29(-4.61%)Hill-Rom Hits New 52-Week High: What's Driving the Stock?Zacks Equity ResearchZacksJanuary 3, 2020ReblogShareTweetShareShares of Hill-Rom Holdings, Inc. HRC reached a new 52-week high of $114.97 on Jan 2, closing the session marginally lower at $113.74. The stock has rallied 5.6% since its third-quarter earnings announcement on Nov 1.The company’s strong third-quarter results, backed by robust Patient Support Systems and global revenue growth, prompted this uptrend.Let us delve deeper. Q3 PerformanceHill-Rom exited fiscal 2019 on a strong note with better-than-expected results. The company saw a solid year-over-year increase in revenues on robust domestic growth, driven by sturdy performances in Patient Support Systems. Internationally, Asia Pacific, Latin America and EMEA registered strong revenue growth.Hill-Rom is upbeat about continuing with the recent trend in the EMEA and the Asia Pacific, aided by a robust improvement in revenues on balanced growth across its segments and all geographies.Other Key DriversAcquisitions: Hill-Rom has been steadily working toward acquisitions to accelerate growth across five key clinical focus areas, such as advancing patient mobility, wound care and prevention, surgical, safety and efficiency, clinical workflow solutions as well as respiratory help. The buyout of Voalte continues to reap benefits for Hill-Rom. In August 2019, the company announced the buyout of Breath Technologies, a developer and manufacturer of a patented nasal cannula technology that enables improved patient mobility. This latest takeover bodes well for Hill-Rom through fiscal 2020 as well.Product Portfolio: Of late, the company is focusing on expansion through product development as reflected in higher research and development expenditure, which buoys optimism. The contribution from new products gave a significant boost to the top line in fiscal 2019. Hill-Rom recently introduced various products like RetinaVue 700 Imager, EarlySense and WatchCare. It expects to register long-lasting growth in the upcoming quarters with strong pipeline of products.Digital Health Space: Investors are upbeat about Hill-Rom’s recently launched smartphone application, Linq mobile. This integrated Clinical Workflows with Nurse Call and clinical surveillance with monitoring systems, which facilitated team communication as well as efficiency. The company has also partnered with Microsoft as a strategic step toward boosting its position in the Digital Health space. This alliance is further expected to contribute to the company’s top line through fiscal 2020.Zacks Rank & Key PicksCurrently, Hill-Rom carries a Zacks Rank #3 (Hold). Some better-ranked stocks from the broader medical space are Haemonetics Corporation HAE, Vapotherm, Inc VAPO and Medtronic plc MDT.Haemonetics has a Zacks Rank #1 (Strong Buy) and a projected long-term earnings growth rate of 13.5%. You can see the complete list of today’s Zacks #1 Rank stocks here.Vapotherm’s long-term earnings growth rate is estimated at 49.5%. The company currently carries a Zacks Rank #2 (Buy).Medtronic’s long-term earnings growth rate is expected at 7.4%. It is currently Zacks #2 Ranked.Biggest Tech Breakthrough in a GenerationBe among the early investors in the new type of device that experts say could impact society as much as the discovery of electricity. Current technology will soon be outdated and replaced by these new devices. In the process, it’s expected to create 22 million jobs and generate $12.3 trillion in activity.A select few stocks could skyrocket the most as rollout accelerates for this new tech. Early investors could see gains similar to buying Microsoft in the 1990s. Zacks’ just-released special report reveals 8 stocks to watch. The report is only available for a limited time.See 8 breakthrough stocks now>>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Medtronic PLC (MDT) : Free Stock Analysis Report Haemonetics Corporation (HAE) : Free Stock Analysis Report Hill-Rom Holdings, Inc. (HRC) : Free Stock Analysis Report Vapotherm, Inc. (VAPO) : Free Stock Analysis Report To read this article on Zacks.com click here. Zacks Investment ResearchReblogShareTweetShareRecently ViewedYour list is empty.What to Read NextAsian markets slammed again as virus fears cause global turmoilAFPA Sliding Share Price Has Us Looking At Glory Sun Financial Group Limited's (HKG:1282) P/E RatioSimply Wall St.Do You Know What China Zhongwang Holdings Limited's (HKG:1333) P/E Ratio Means?Simply Wall St.Dollar Bond Market in Asia Gets Rougher for Virus-Hit BorrowersBloombergMarriott closes nearly a quarter of China hotels amid coronavirus concernsAmerican City Business JournalsRichard Branson’s Wealth Falls to Earth as Virgin Galactic SputtersBloombergA drug shortage due to the coronavirus is a 'considerable risk:' Fmr. FDA deputy commissionerYahoo Finance VideoBiocontainment expert on coronavirus: There's no need for average people to panic yetYahoo FinanceAmid coronavirus, bitcoin has fallen 6% this week to below $8,800Yahoo FinanceEl-Erian: The Fed will cut rates in March, if not beforeYahoo Finance VideoHere are 5 reasons the stock market is having its worst decline since 2008, and only one of them is the coronavirusMarketWatchMost face masks won’t protect you from the coronavirusYahoo FinanceStock market live updates: Dow drops 1190 points amid coronavirus fears, S&P 500 sees fastest correction in historyYahoo FinanceDon’t buy the stock dip yet, says Goldman as it warns coronavirus will wipe out earnings growth this yearMarketWatchCoronavirus-induced stock selloff means IPO market is 'on holiday': veteran IPO analystYahoo FinanceMarket Watcher: Over six months we will see the markets higher Yahoo Finance Video